R&D Views & Analysis | pharmaphorum

Views & Analysis

Ipsen’s John Chaddock on making neurotoxins a priority for h...

Injected neurotoxins can be incredibly potent in treating spasticity from neurological diseases, but the field doesn’t always get the attention it needs. Ipsen’s John Chaddock tells u

R&D

Richard Francis on his Purespring plans: the pharmaphorum po...

In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this mont

Views & Analysis

Increasing patient engagement with UK clinical trials

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and

Views & Analysis

Casting aside CRISPR scissors and making a point with base e...

Dr Jennifer Harbottle, senior scientist in the R&D Base Editing team of PerkinElmer’s Horizon Discovery business, looks at progress made in the realms of biotechnology and next-generati

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

Virtual trials and the next generation of pharma clinical re...

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition.

Views & Analysis

Gene editing: beyond the hype

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities.

Ipsen’s John Chaddock on making neurotoxins a priority for h...

Richard Francis on his Purespring plans: the pharmaphorum po...

Increasing patient engagement with UK clinical trials

Casting aside CRISPR scissors and making a point with base e...

Virtual trials and the next generation of pharma clinical re...

Gene editing: beyond the hype

UK seeks views on indefinite CE marks for medical devices

How to meet your physicians where they are online

Views & Analysis

Editor's Picks